Table A5.
Comparison of frequency of clinical features in the 2 years prior to diagnosis between NSCLC and SCLC.
| All Patients (n = 711) |
NSCLC and SCLC (n = 609) | NSLCL (n = 546) | SCLC (n = 63) | p-Value | |
|---|---|---|---|---|---|
| Cough | 573 (80.59%) | 505 (82.9%) | 450 (82.4%) | 55 (87.3%) | 0.4245 |
| Shortness of breath | 515 (72.43%) | 445 (73.1%) | 398 (72.9%) | 47 (74.6%) | 0.8889 |
| Fatigue | 476 (66.95%) | 412 (67.7%) | 368 (67.4%) | 44 (69.8%) | 0.8025 |
| Chest Pain | 403 (56.68%) | 356 (58.5%) | 316 (57.9%) | 40 (63.5%) | 0.4706 |
| Chest crackles or wheeze | 397 (55.84%) | 342 (56.2%) | 302 (55.3%) | 40 (63.5%) | 0.2692 |
| Back pain | 350 (49.23%) | 301 (49.4%) | 271 (49.6%) | 30 (47.6%) | 0.8652 |
| Weight loss | 308 (43.32%) | 260 (42.7%) | 237 (43.4%) | 23 (36.5%) | 0.3609 |
| Bone pain | 270 (37.97%) | 244 (40.1%) | 222 (40.7%) | 22 (34.9%) | 0.4567 |
| Lymphadenopathy | 151 (21.24%) | 131 (21.5%) | 110 (20.1%) | 21 (33.3%) | 0.0244 |
| Hemoptysis | 118 (16.60%) | 98 (16.1%) | 88 (16.1%) | 10 (15.9%) | 1.0000 |
| Finger clubbing | 39 (5.49%) | 33 (5.4%) | 32 (5.9%) | 1 (1.6%) | 0.2607 |
Footnotes: Excludes individuals with stage 0 or unknown stage. Excludes asymptomatic people but includes screen-detected individuals.